원문정보
초록
영어
Vascular cell adhesion molecule-1 (VCAM-1) is a member of the diverse cellular adhesion
molecule family which includes intergrins, selectins, and the immunoglobulin superfamily and is
a critical component of the leukocyte-endothelial adhesion cascade. VCAM-1 is upregulated on
the endothelial under inflammatory conditions including autoimmune inflammatory diseases,
atherosclerosis and organ transplantation rejection.
Transendothelial migration of inflammatory cells is a key step in autoimmune inflammatory
diseases (asthma, rheumatoid arthritis, IBD (inflammatory bowel disease)) and is mediated by
the presence of cell adhesion molecule, including VCAM-1, on the vascular endothelium.
Activated vascular endothelial cell expresses VCAM-1 which can be bound by inflammatory cells
expressing very late antigen-4 (VLA-4), the ligand of VCAM-1. VCAM-1-VLA-4 interaction
plays a vital role in the passage of the inflammatory cell between endothelial cells. Currently,
increasing attention is being paid to VCAM-1-VLA-4 interaction as targets for therapeutic
interventions in inflammatory diseases.
The goal of this study is to develop a novel cross-species specific anti-VCAM-1 therapeutic
antibody for inflammatory disease treatments, which has better advantages for the evaluation of
therapeutic efficacy in preclinical animal models.